Literature DB >> 28820724

Neurologic Complications in Persons With HIV Infection in the Era of Antiretroviral Therapy.

Dennis Kolson1.   

Abstract

Neurologic complications in persons with HIV infection are less severe in the era of potent antiretroviral therapy but remain highly prevalent. Prior to the use of antiretroviral therapy, opportunistic infections of the central nervous system (CNS) and CNS malignancy were common. Progressive multifocal leukoencephalopathy (PML), however, remains a diagnostic challenge in HIV-infected individuals, and no effective antiviral treatment for PML is currently available. Primary neurologic complications of acute HIV infection include aseptic meningitis and acute inflammatory demyelinating polyneuropathy. Among the neurologic complications of chronic HIV infection, HIV-associated neurocognitive disorders (HAND) remain most prevalent. The use of antiretroviral therapy has greatly reduced the severity of HAND, under which progressive HIV-associated dementia once predominated, to a milder chronic form of potentially disabling neurocognitive impairment. The persistence of HAND in individuals with virologic suppression suggests a need for adjunctive therapies for limiting its morbidity. This article summarizes a presentation by Dennis Kolson, MD, PhD, at the IAS-USA continuing education program, Improving the Management of HIV Disease, held in Chicago, Illinois, in May 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28820724      PMCID: PMC5935214     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN: 2161-5853


  35 in total

1.  HIV persistence in macrophages.

Authors:  Mario Stevenson
Journal:  Nat Med       Date:  2017-05-05       Impact factor: 53.440

Review 2.  Manifestations of HIV infection in the peripheral nervous system.

Authors:  Chad M Centner; Kathleen J Bateman; Jeannine M Heckmann
Journal:  Lancet Neurol       Date:  2013-03       Impact factor: 44.182

3.  Central nervous system viral invasion and inflammation during acute HIV infection.

Authors:  Victor Valcour; Thep Chalermchai; Napapon Sailasuta; Mary Marovich; Sukalaya Lerdlum; Duanghathai Suttichom; Nijasri C Suwanwela; Linda Jagodzinski; Nelson Michael; Serena Spudich; Frits van Griensven; Mark de Souza; Jerome Kim; Jintanat Ananworanich
Journal:  J Infect Dis       Date:  2012-05-02       Impact factor: 5.226

4.  Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study.

Authors:  Arvid Edén; Staffan Nilsson; Lars Hagberg; Dietmar Fuchs; Henrik Zetterberg; Bo Svennerholm; Magnus Gisslén
Journal:  J Infect Dis       Date:  2016-09-28       Impact factor: 5.226

5.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Authors:  Scott Letendre; Jennifer Marquie-Beck; Edmund Capparelli; Brookie Best; David Clifford; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; Susan Morgello; David Simpson; Igor Grant; Ronald J Ellis
Journal:  Arch Neurol       Date:  2008-01

6.  Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders.

Authors:  Alexander J Gill; Colleen E Kovacsics; Stephanie A Cross; Patricia J Vance; Lorraine L Kolson; Kelly L Jordan-Sciutto; Benjamin B Gelman; Dennis L Kolson
Journal:  J Clin Invest       Date:  2014-09-09       Impact factor: 14.808

Review 7.  CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogens.

Authors:  M J D Post; M M Thurnher; D B Clifford; A Nath; R G Gonzalez; R K Gupta; K K Post
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

8.  Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder.

Authors:  Thomas M Gates; Lucette A Cysique; Krista J Siefried; Joga Chaganti; Kirsten J Moffat; Bruce J Brew
Journal:  AIDS       Date:  2016-02-20       Impact factor: 4.177

Review 9.  Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered.

Authors:  Benjamin B Gelman
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

10.  Macrophage infection via selective capture of HIV-1-infected CD4+ T cells.

Authors:  Amy E Baxter; Rebecca A Russell; Christopher J A Duncan; Michael D Moore; Christian B Willberg; Jose L Pablos; Andrés Finzi; Daniel E Kaufmann; Christina Ochsenbauer; John C Kappes; Fedde Groot; Quentin J Sattentau
Journal:  Cell Host Microbe       Date:  2014-11-20       Impact factor: 21.023

View more
  7 in total

1.  White matter microstructure among perinatally HIV-infected youth: a diffusion tensor imaging study.

Authors:  Manoj K Sarma; Margaret A Keller; Paul M Macey; David E Michalik; Judy Hayes; Karin Nielsen-Saines; Jaime Deville; Joseph A Church; Irwin Walot; M Albert Thomas
Journal:  J Neurovirol       Date:  2019-01-04       Impact factor: 2.643

2.  Brain macrophages harbor latent, infectious simian immunodeficiency virus.

Authors:  Celina Abreu; Erin N Shirk; Suzanne E Queen; Sarah E Beck; Lisa M Mangus; Kelly A M Pate; Joseph L Mankowski; Lucio Gama; Janice E Clements
Journal:  AIDS       Date:  2019-12-01       Impact factor: 4.177

Review 3.  Co-receptor signaling in the pathogenesis of neuroHIV.

Authors:  E A Nickoloff-Bybel; L Festa; O Meucci; P J Gaskill
Journal:  Retrovirology       Date:  2021-08-24       Impact factor: 4.602

4.  A Rare Case of HIV-Induced Inflammatory Demyelinating Polyneuropathy.

Authors:  Abin Sajan; Soombal Zahid; Jordan Stumph; Daniel Griepp; Sami Saba; Nazish Ilyas; Isabel M McFarlane
Journal:  Am J Med Case Rep       Date:  2019-01-21

5.  Clinical Characteristics of Peripheral Neuropathy in Kenyan Patients with HIV Infection Compared with Patients with Concurrent HIV Infection and Diabetes Mellitus.

Authors:  Werimo Pascal Kuka; Jasmit Shah; Uazman Alam; Reena Shah; Dilraj Singh Sokhi
Journal:  Diabetes Ther       Date:  2022-02-14       Impact factor: 2.945

6.  Neuroinflammation and EIF2 Signaling Persist despite Antiretroviral Treatment in an hiPSC Tri-culture Model of HIV Infection.

Authors:  Sean K Ryan; Michael V Gonzalez; James P Garifallou; Frederick C Bennett; Kimberly S Williams; Nathaniel P Sotuyo; Eugene Mironets; Kieona Cook; Hakon Hakonarson; Stewart A Anderson; Kelly L Jordan-Sciutto
Journal:  Stem Cell Reports       Date:  2020-03-26       Impact factor: 7.765

7.  Lateral amyotrophic sclerosis-like onset after combined antiretroviral treatment initiation.

Authors:  Andres Quevedo-Ramirez; Juan Jose Montenegro-Idrogo; Cristhian Resurrección-Delgado; Blanca Salazar-Mesones; Jorge Gallardo-Cartagena; Gonzalo Cornejo-Venegas; Carolina Méndez-Guerra; Iván Vargas-Matos; Alfredo Chiappe-Gonzalez
Journal:  IDCases       Date:  2020-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.